Hempalta (CVE:HEMP) Shares Up 33.3% – Time to Buy?

Shares of Hempalta Corp. (CVE:HEMP – Get Free Report) shot up 33.3% during mid-day trading on Friday . The company traded as high as C$0.07 and last traded at C$0.06. 182,500 shares changed hands during mid-day trading, an increase of 77% from the average session volume of 103,117 shares. The stock had previously closed at [...]

featured-image

Shares of Hempalta Corp. ( CVE:HEMP – Get Free Report ) shot up 33.3% during mid-day trading on Friday .

The company traded as high as C$0.07 and last traded at C$0.06.



182,500 shares changed hands during mid-day trading, an increase of 77% from the average session volume of 103,117 shares. The stock had previously closed at C$0.05.

Hempalta Price Performance The company has a quick ratio of 0.88, a current ratio of 3.99 and a debt-to-equity ratio of 28.

72. The company has a market capitalization of C$5.70 million, a P/E ratio of -0.

48 and a beta of -0.10. The business has a 50 day simple moving average of C$0.

05 and a 200-day simple moving average of C$0.09. Insider Buying and Selling at Hempalta In other news, Director Darren Hartley Bondar sold 453,000 shares of the firm’s stock in a transaction on Monday, January 6th.

The stock was sold at an average price of C$0.06, for a total transaction of C$26,274.00.

Over the last three months, insiders have purchased 610,474 shares of company stock worth $27,499. 27.90% of the stock is owned by insiders.

About Hempalta Hempalta Corp., an agricultural cleantech company, produces and processes industrial hemp in North America. It manufactures products using a process known as HempTrain that enables to produce a range of hemp-based commercial and consumer products.

The company also engages in the hemp carbon credit market. Featured Articles Five stocks we like better than Hempalta 3 Must-Buy Warren Buffett Stocks for Volatile Times Bloom Energy: Powering the Future With Decentralized Energy How to Use High Beta Stocks to Maximize Your Investing Profits Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul How to Know Which Cryptocurrency to Buy: A Guide for Investors Why Traders Are Buying the Dip on Johnson & Johnson Stock Receive News & Ratings for Hempalta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hempalta and related companies with MarketBeat.com's FREE daily email newsletter .

.